Tratamiento Dirigido en el Cáncer de Pulmón Microcítico: El Papel de los Marcadores

59 / 62

Yu et al. JTO 2017
• The overall prevalence of PD-L1 protein expression in tumor cells was 16.5%.
• The prevalence of PD-L1 in SCLC is lower than that published for NSCLC .
PD-L1 expression in SCLC